Biotech · Private company
Ancora Heart, Inc.
Track this companyFree. Adds Ancora Heart, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials41 recruiting or active
Pipeline programs5From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline5
- AccuCinch Ventricular Restoration SystemHeart Failure With Reduced Ejection Fraction (HFrEF)ClinicalTrials.gov · fetched Nov 12, 2026
- AccuCinch® Ventricular RestorationHeart FailureClinicalTrials.gov · fetched Nov 12, 2026
- AccuCinch® Ventricular Restoration SystemHeart FailureClinicalTrials.gov · fetched Nov 12, 2026
- Guideline-Directed Medical TherapyHeart Failure With Reduced Ejection Fraction (HFrEF)ClinicalTrials.gov · fetched Nov 12, 2026
- Mitral valve repairHeart FailureClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF StudyNA · SUSPENDED · started Dec 21, 2020ClinicalTrials.gov NCT04331769 · fetched Nov 12, 2026
- Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral RegurgitationNA · COMPLETED · started Sep 24, 2018ClinicalTrials.gov NCT03560167 · fetched Nov 12, 2026
- Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection FractionNA · ACTIVE_NOT_RECRUITING · started Aug 23, 2018ClinicalTrials.gov NCT03533517 · fetched Nov 12, 2026
- The CorCinch - Functional Mitral Valve Regurgitation (FMR) StudyNA · COMPLETED · started Aug 1, 2016ClinicalTrials.gov NCT02806570 · fetched Nov 12, 2026